Main Street Research LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,238 shares of the medical equipment provider's stock after purchasing an additional 707 shares during the period. Intuitive Surgical accounts for 2.6% of Main Street Research LLC's holdings, making the stock its 16th biggest holding. Main Street Research LLC's holdings in Intuitive Surgical were worth $39,739,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the stock. AlphaCore Capital LLC grew its holdings in Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the period. Accredited Investors Inc. boosted its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after purchasing an additional 19 shares during the last quarter. Second Line Capital LLC grew its stake in shares of Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the period. Colonial Trust Co SC increased its holdings in shares of Intuitive Surgical by 8.8% during the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after buying an additional 20 shares during the last quarter. Finally, Crown Wealth Group LLC increased its holdings in shares of Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after buying an additional 20 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Trading Down 0.1%
NASDAQ ISRG traded down $0.50 during trading hours on Thursday, reaching $527.64. The company's stock had a trading volume of 686,985 shares, compared to its average volume of 1,670,252. The business has a 50-day simple moving average of $538.02 and a 200 day simple moving average of $536.87. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The stock has a market cap of $189.11 billion, a PE ratio of 77.41, a PEG ratio of 5.59 and a beta of 1.64.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the business posted $1.50 EPS. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Analyst Ratings Changes
ISRG has been the topic of a number of research analyst reports. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Evercore ISI lifted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday. Finally, Citigroup reiterated a "buy" rating and set a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $592.59.
Check Out Our Latest Analysis on Intuitive Surgical
Insider Activity
In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director owned 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by insiders.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.